Korea Research Institute of Bioscience and Biotechnology;Seoul National University R & DB Foundation
发明人:
申请号：
EP18735838.7
公开号：
EP3567101A1
申请日:
2018.01.05
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to a natural killer cell expressing an anti-cotinine chimeric antigen receptor (CAR) specifically binding to cotinine, and a cell therapeutic agent comprising same. The natural killer cell expressing a chimeric antigen receptor specifically binding to cotinine, according to the present invention, can effectively move to tumor tissue, regardless of the kind of cancer, depending on the binding substance bound to cotinine. Therefore, the natural killer cell according to the present invention can be usefully employed as a gene therapy exhibiting a highly efficient anticancer effect.
